Zhejiang Xinguang Pharmaceutical Co Ltd
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquar… Read more
Zhejiang Xinguang Pharmaceutical Co Ltd (300519) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.006x
Based on the latest financial reports, Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a cash flow conversion efficiency ratio of -0.006x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-5.00 Million) by net assets (CN¥814.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Xinguang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Xinguang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Xinguang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Xinguang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Playtika Holding Corp
NASDAQ:PLTK
|
-1.563x |
|
Tien Phong Securities Corp
VN:ORS
|
0.317x |
|
TASKUS INC. CL.A DL-01
F:6VY
|
N/A |
|
USANA Health Sciences Inc
NYSE:USNA
|
-0.003x |
|
SOLSTAD OFFSHORE NK 1
F:SZL
|
N/A |
|
Changchun Zhiyuan New Energy Equipment Co. Ltd
SHE:300985
|
0.112x |
|
Orogen Royalties Inc
PINK:OGNRF
|
0.017x |
|
Smart Eye AB
ST:SEYE
|
0.002x |
Annual Cash Flow Conversion Efficiency for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥830.53 Million | CN¥53.43 Million | 0.064x | +1.91% |
| 2023-12-31 | CN¥844.12 Million | CN¥53.29 Million | 0.063x | -57.11% |
| 2022-12-31 | CN¥858.89 Million | CN¥126.43 Million | 0.147x | -12.50% |
| 2021-12-31 | CN¥846.22 Million | CN¥142.36 Million | 0.168x | +23.53% |
| 2020-12-31 | CN¥826.94 Million | CN¥112.61 Million | 0.136x | +10.82% |
| 2019-12-31 | CN¥799.71 Million | CN¥98.27 Million | 0.123x | -0.23% |
| 2018-12-31 | CN¥753.26 Million | CN¥92.77 Million | 0.123x | -30.03% |
| 2017-12-31 | CN¥705.81 Million | CN¥124.23 Million | 0.176x | -6.98% |
| 2016-12-31 | CN¥640.46 Million | CN¥121.18 Million | 0.189x | -53.11% |
| 2015-12-31 | CN¥309.35 Million | CN¥124.84 Million | 0.404x | +0.67% |
| 2014-12-31 | CN¥249.00 Million | CN¥99.82 Million | 0.401x | +40.78% |
| 2013-12-31 | CN¥201.97 Million | CN¥57.51 Million | 0.285x | -25.23% |
| 2012-12-31 | CN¥141.62 Million | CN¥53.93 Million | 0.381x | +15.50% |
| 2011-12-31 | CN¥104.32 Million | CN¥34.40 Million | 0.330x | -- |